Australian researchers analyzed 206 international publications evaluating intensive care unit pneumonia prevention methods.
They found an average of 23.7 percent of patients receiving prolonged mechanical ventilation experienced VAP. For patients receiving topical antibiotics, an average of 38 percent developed VAP.
“The contextual effect of topical antibiotics is paradoxic, peculiar, potent, perfidious and potentially perilous,” researchers conclude.
More articles on HAIs:
C. diff meets its match in natural gut flora
Preventing SSIs: The sterile processing connection
Mission Hospital resumes elective surgeries after infection issue
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.